A Study of MK-7240 in Healthy Participants (MK-7240-009)

Sponsor
Merck Sharp & Dohme LLC
Study ID
NCT07405177
Phase
PHASE1
Status
Active Not Recruiting

Conditions

  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

Study Details

The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.

Key Dates

Start date
Mar 5, 2026
Status verified
Jun 2026
Primary completion
Sep 3, 2026
Completion
Sep 3, 2026

Study Design

Enrollment
330 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Arm 1: Tulisokibart Form 1
    Participants will receive tulisokibart form 1.
  • Experimental: Arm 2: Tulisokibart Form 2
    Participants will receive tulisokibart form 2.

Primary Outcome Measure

Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Tulisokibart [ Time Frame: At designated timepoints up to 14 weeks ]

Related Studies